Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria | 3 | 2018 | 487 | 0.860 |
Why?
|
| Chlorides | 2 | 2013 | 56 | 0.840 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2021 | 36 | 0.770 |
Why?
|
| Kidney Neoplasms | 1 | 2021 | 68 | 0.750 |
Why?
|
| Prostatic Neoplasms | 4 | 2018 | 935 | 0.710 |
Why?
|
| Repressor Proteins | 1 | 2021 | 249 | 0.660 |
Why?
|
| DNA, Mitochondrial | 1 | 2018 | 175 | 0.600 |
Why?
|
| Oxidative Stress | 3 | 2013 | 938 | 0.590 |
Why?
|
| Manganese Compounds | 2 | 2013 | 16 | 0.520 |
Why?
|
| Neuroprotective Agents | 2 | 2017 | 245 | 0.480 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2014 | 32 | 0.480 |
Why?
|
| DNA Breaks, Single-Stranded | 1 | 2013 | 13 | 0.440 |
Why?
|
| Proteome | 1 | 2014 | 144 | 0.440 |
Why?
|
| Manganese Poisoning | 1 | 2013 | 22 | 0.430 |
Why?
|
| Estradiol | 1 | 2014 | 262 | 0.420 |
Why?
|
| Acetylcysteine | 1 | 2013 | 62 | 0.420 |
Why?
|
| Glutathione | 1 | 2013 | 179 | 0.410 |
Why?
|
| Proteomics | 1 | 2014 | 325 | 0.410 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 306 | 0.380 |
Why?
|
| Antioxidants | 2 | 2013 | 416 | 0.360 |
Why?
|
| Cell Survival | 6 | 2015 | 864 | 0.310 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2015 | 1039 | 0.300 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 1015 | 0.300 |
Why?
|
| Neurons | 1 | 2013 | 1175 | 0.260 |
Why?
|
| Microglia | 2 | 2018 | 166 | 0.260 |
Why?
|
| Manganese | 2 | 2017 | 87 | 0.240 |
Why?
|
| Databases, Genetic | 1 | 2021 | 93 | 0.190 |
Why?
|
| Cell Line, Tumor | 5 | 2017 | 2231 | 0.190 |
Why?
|
| Biomedical Research | 2 | 2024 | 400 | 0.190 |
Why?
|
| Survival Rate | 1 | 2021 | 311 | 0.180 |
Why?
|
| Male | 8 | 2024 | 20025 | 0.170 |
Why?
|
| Lipopolysaccharides | 2 | 2018 | 220 | 0.170 |
Why?
|
| Prognosis | 1 | 2021 | 739 | 0.160 |
Why?
|
| Humans | 11 | 2024 | 37093 | 0.160 |
Why?
|
| Oxidative Phosphorylation | 1 | 2018 | 53 | 0.160 |
Why?
|
| Hydrolyzable Tannins | 1 | 2018 | 16 | 0.160 |
Why?
|
| Apoptosis | 2 | 2018 | 1398 | 0.160 |
Why?
|
| Aggression | 1 | 2018 | 89 | 0.160 |
Why?
|
| Environment | 1 | 2018 | 138 | 0.150 |
Why?
|
| Butyric Acid | 1 | 2017 | 18 | 0.150 |
Why?
|
| Interferon-gamma | 1 | 2018 | 250 | 0.150 |
Why?
|
| Valproic Acid | 1 | 2017 | 16 | 0.150 |
Why?
|
| Excitatory Amino Acid Transporter 1 | 1 | 2017 | 16 | 0.150 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 123 | 0.150 |
Why?
|
| Contrast Media | 1 | 2017 | 92 | 0.150 |
Why?
|
| Health Status Disparities | 2 | 2014 | 642 | 0.140 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 169 | 0.140 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2017 | 38 | 0.140 |
Why?
|
| Liposomes | 1 | 2017 | 118 | 0.140 |
Why?
|
| Life Style | 1 | 2018 | 308 | 0.140 |
Why?
|
| Socioeconomic Factors | 2 | 2018 | 1067 | 0.140 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 461 | 0.140 |
Why?
|
| Pancreatic Neoplasms | 1 | 2017 | 111 | 0.130 |
Why?
|
| NF-kappa B | 1 | 2018 | 339 | 0.130 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 2379 | 0.130 |
Why?
|
| Benzoquinones | 1 | 2015 | 36 | 0.130 |
Why?
|
| Neoplasms | 2 | 2024 | 1103 | 0.130 |
Why?
|
| Young Adult | 3 | 2021 | 4268 | 0.120 |
Why?
|
| Astrocytes | 1 | 2017 | 255 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 481 | 0.120 |
Why?
|
| Motor Activity | 1 | 2017 | 418 | 0.120 |
Why?
|
| Florida | 3 | 2024 | 410 | 0.120 |
Why?
|
| Disease | 1 | 2013 | 18 | 0.120 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2012 | 864 | 0.110 |
Why?
|
| Testosterone | 1 | 2014 | 193 | 0.110 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 149 | 0.110 |
Why?
|
| Genetic Markers | 1 | 2013 | 142 | 0.110 |
Why?
|
| Hydrogen Peroxide | 2 | 2012 | 190 | 0.110 |
Why?
|
| Thymine | 1 | 2013 | 25 | 0.110 |
Why?
|
| Comet Assay | 1 | 2013 | 76 | 0.110 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2013 | 133 | 0.110 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2013 | 81 | 0.110 |
Why?
|
| DNA Repair | 1 | 2013 | 188 | 0.100 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2013 | 206 | 0.100 |
Why?
|
| Heme Oxygenase-1 | 1 | 2012 | 51 | 0.100 |
Why?
|
| PC12 Cells | 1 | 2012 | 93 | 0.100 |
Why?
|
| Education, Pharmacy | 1 | 2012 | 43 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2013 | 399 | 0.100 |
Why?
|
| Lactic Acid | 1 | 2012 | 95 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2015 | 1207 | 0.100 |
Why?
|
| Clinical Competence | 1 | 2012 | 130 | 0.100 |
Why?
|
| Students, Pharmacy | 1 | 2012 | 47 | 0.100 |
Why?
|
| Aged | 2 | 2021 | 6741 | 0.100 |
Why?
|
| Cultural Competency | 1 | 2012 | 131 | 0.090 |
Why?
|
| Adult | 4 | 2021 | 11712 | 0.090 |
Why?
|
| Middle Aged | 3 | 2021 | 10129 | 0.090 |
Why?
|
| Glucose | 1 | 2012 | 230 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 803 | 0.090 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 421 | 0.090 |
Why?
|
| Animals | 7 | 2018 | 15081 | 0.090 |
Why?
|
| Female | 4 | 2024 | 20969 | 0.080 |
Why?
|
| Gene Expression | 1 | 2012 | 674 | 0.080 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1198 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 626 | 0.080 |
Why?
|
| Oxidopamine | 2 | 2005 | 20 | 0.080 |
Why?
|
| Minority Groups | 2 | 2024 | 596 | 0.080 |
Why?
|
| Time Factors | 1 | 2012 | 1742 | 0.070 |
Why?
|
| Rats | 2 | 2012 | 3483 | 0.070 |
Why?
|
| Smoke | 1 | 2005 | 40 | 0.060 |
Why?
|
| Neurotoxins | 1 | 2005 | 57 | 0.060 |
Why?
|
| Health Behavior | 1 | 2008 | 537 | 0.060 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 128 | 0.060 |
Why?
|
| Neuroglia | 1 | 2005 | 124 | 0.060 |
Why?
|
| Glycolysis | 1 | 2004 | 68 | 0.060 |
Why?
|
| Education, Distance | 1 | 2024 | 44 | 0.060 |
Why?
|
| United States | 3 | 2024 | 4223 | 0.050 |
Why?
|
| Research Personnel | 1 | 2024 | 155 | 0.050 |
Why?
|
| California | 1 | 2024 | 476 | 0.050 |
Why?
|
| Nitrites | 2 | 2015 | 46 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2015 | 115 | 0.050 |
Why?
|
| Universities | 1 | 2024 | 442 | 0.050 |
Why?
|
| Mice | 3 | 2018 | 5913 | 0.040 |
Why?
|
| Smoking | 1 | 2005 | 940 | 0.040 |
Why?
|
| Phantoms, Imaging | 1 | 2017 | 24 | 0.040 |
Why?
|
| Viscosity | 1 | 2017 | 38 | 0.040 |
Why?
|
| Gadolinium | 1 | 2017 | 27 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2017 | 88 | 0.040 |
Why?
|
| Rotarod Performance Test | 1 | 2017 | 14 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 122 | 0.040 |
Why?
|
| Deoxycytidine | 1 | 2017 | 22 | 0.040 |
Why?
|
| Cerebellum | 1 | 2017 | 73 | 0.040 |
Why?
|
| Hot Temperature | 1 | 2017 | 128 | 0.040 |
Why?
|
| Particle Size | 1 | 2017 | 215 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2017 | 337 | 0.040 |
Why?
|
| Students | 1 | 2021 | 519 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2017 | 202 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2015 | 91 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 290 | 0.030 |
Why?
|
| Lysine | 1 | 2015 | 113 | 0.030 |
Why?
|
| Cell Line | 1 | 2018 | 1354 | 0.030 |
Why?
|
| Hormone Replacement Therapy | 1 | 2014 | 41 | 0.030 |
Why?
|
| Age Distribution | 1 | 2014 | 225 | 0.030 |
Why?
|
| Models, Biological | 1 | 2017 | 677 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 448 | 0.030 |
Why?
|
| Magnesium | 1 | 2013 | 97 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 433 | 0.030 |
Why?
|
| Nanoparticles | 1 | 2017 | 318 | 0.030 |
Why?
|
| Health Surveys | 1 | 2014 | 373 | 0.030 |
Why?
|
| Alleles | 1 | 2013 | 321 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2012 | 2721 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 1609 | 0.030 |
Why?
|
| Schools, Pharmacy | 1 | 2012 | 18 | 0.030 |
Why?
|
| Professional-Patient Relations | 1 | 2012 | 48 | 0.030 |
Why?
|
| Awareness | 1 | 2012 | 65 | 0.030 |
Why?
|
| Cultural Characteristics | 1 | 2012 | 125 | 0.020 |
Why?
|
| Cytokines | 1 | 2015 | 602 | 0.020 |
Why?
|
| Prejudice | 1 | 2012 | 110 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 689 | 0.020 |
Why?
|
| Cultural Diversity | 1 | 2012 | 169 | 0.020 |
Why?
|
| Language | 1 | 2012 | 157 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2012 | 198 | 0.020 |
Why?
|
| Curriculum | 1 | 2012 | 265 | 0.020 |
Why?
|
| Nigeria | 1 | 2008 | 86 | 0.020 |
Why?
|
| Mutation | 1 | 2013 | 1095 | 0.020 |
Why?
|
| Emigrants and Immigrants | 1 | 2008 | 137 | 0.020 |
Why?
|
| Child | 1 | 2014 | 3131 | 0.020 |
Why?
|
| Sympatholytics | 1 | 2005 | 14 | 0.020 |
Why?
|
| Oxidants | 1 | 2005 | 45 | 0.020 |
Why?
|
| Monoamine Oxidase | 1 | 2005 | 34 | 0.020 |
Why?
|
| Pyridinium Compounds | 1 | 2005 | 27 | 0.020 |
Why?
|
| Mass Screening | 1 | 2008 | 462 | 0.020 |
Why?
|
| Cell Respiration | 1 | 2004 | 35 | 0.010 |
Why?
|
| Glioma | 1 | 2005 | 79 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 2005 | 129 | 0.010 |
Why?
|
| Adolescent | 1 | 2014 | 5363 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2004 | 431 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 859 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2005 | 316 | 0.010 |
Why?
|
| Risk Factors | 1 | 2008 | 3562 | 0.010 |
Why?
|